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Abstract
Human erythrocyte spectrin was labelled with the probe 5,5P-disulfato-1-(6-hexanoic acid N-hydroxysuccinimide ester)-1P-
ethyl-3,3,3P,3P-tetramethylindocarbocyanine (Cy3). Cy3-spectrin was bound to the outer surface of dimyristoylphos-
phatidylcholine (DMPC) multilamellar vesicles and its diffusion measured by fluorescence recovery after photobleaching
(FRAP). It was found that at 30‡C, above the lipid gel to liquid-crystalline phase transition of the lipids, Cy3-spectrin had an
unexpectedly high diffusion coefficient D = (2.1 þ 0.6)U1037 cm2/s. At the phase transition, diffusion of Cy3-spectrin was
only slightly lower; D = (1.3 þ 0.3)U1037 cm2/s, whereas at 14‡C, well below the lipid phase transition, diffusion was found
to be much slower with D = (3.1 þ 0.12)U1039 cm2/s. The fast diffusion of Cy3-spectrin on the lipid surface implies that the
individual bonds which bind spectrin to the lipid surface must rapidly be made and broken. In the light of these results,
spectrin^lipid interactions alone appear unlikely to have any significant role in supporting the cell membrane. Probably, the
interactions serve only to localise the spectrin at the inner lipid surface in order to facilitate formation of the
cytoskeleton. ß 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
Spectrin is the predominant component of the
erythrocyte cytoskeleton that adds strength to the
cell membrane and helps maintain the erythrocyte
shape. It is well documented that the erythrocyte
cytoskeleton is bound to the erythrocyte membrane
through interactions between both cytoskeletal pro-
teins and transmembrane proteins [1,2]. Spectrin is
coupled to the transmembrane protein, band 3, via
ankyrin and to another transmembrane protein, gly-
cophorin C via protein 4.1. Spectrin is also linked to
vertices composed predominantly of actin oligomers,
protein 4.1 and other accessory proteins. However,
there is an increasing body of evidence that spectrin
can also interact with the lipids on the inner mem-
brane lea£et. The signi¢cance of such spectrin^lipid
interactions is as yet unknown but many di¡erent
roles have been postulated. Early studies suggested
that spectrin^lipid interactions helped maintain the
lipid asymmetry of the erythrocyte membrane but
this is no longer thought to be the case since the
role of an ATP-driven lipid translocase was eluci-
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dated [3^5]. Other possible roles for spectrin^lipid
interactions include the further strengthening and
shape regulation of the cell membrane or to direct
and concentrate unbound spectrin molecules at the
inner lipid lea£et to facilitate protein^protein inter-
actions [6].
Erythroid spectrin is a dimer consisting of K and L
subunits with molecular masses of 270 kDa [7] and
246 kDa [8], respectively. Spectrin dimers can form
higher oligomers by head-to-head interactions, with
tetramers being predominant within intact erythro-
cytes [9]. The K- and L-subunits of spectrin exhibit
homology, both sharing a common 106-amino-acid
repeat motif which forms a structurally identical bar-
rel, composed of 3 K-helices [10^12]. The subunits
interact along their length to form a coiled-coil like
rod structure of V100 nm [12^15] that can compress
and expand together.
The lipid speci¢city of spectrin^lipid interactions is
still unclear since di¡erent studies have produced
con£icting evidence. The majority of studies of spec-
trin^lipid interactions have shown that spectrin can
interact with both neutral and negatively charged
lipids. The binding a⁄nity of spectrin for negatively
charged lipids has in some studies been shown to be
higher than that of spectrin^neutral lipid interactions
[16^20]. Other studies, however, have shown spectrin
a⁄nities for both neutral and negatively charged lip-
ids to be similar [21^23]. It was also suggested in
some of the earlier studies that spectrin may insert
into the lipid bilayers [16^18], but a more recent
study found no evidence for this in bilayer vesicles
[21]. Finally, there is one report that spectrin does
not bind to neutral or negatively charged lipids with
signi¢cant a⁄nity [24].
Spectrin^lipid interaction studies have up to now
focused on the type of interaction and the binding
a⁄nities of spectrin for various lipids and under
varying conditions, but the mobility of spectrin on
the lipid surfaces has not previously been investi-
gated. Such studies could provide further insight
into the nature of spectrin^lipid interactions. In this
study, £uorescence recovery after photobleaching
(FRAP) has been used to analyse the di¡usion of
Cy3-labelled spectrin bound to the outer lipid surface
of DMPC multilamellar vesicles (MLVs) above
and below the phase transition temperature of the
lipids.
2. Materials and methods
2.1. Materials
Cy3 was purchased from Amersham (Cambridge
Biosciences). DMPC was purchased from Sigma.
2.2. Puri¢cation of erythrocyte spectrin
Spectrin was puri¢ed from freshly drawn blood
according to the method of Takeshita et al. [20],
and its purity checked by 7.5% SDS^PAGE accord-
ing to the method of Laemmli [25].
2.3. Cy3 labelling of spectrin
Cy3 labelling of spectrin has been previously de-
scribed by Cherry et al. [26]. Brie£y, spectrin was
dialysed into 5 mM sodium phosphate (pH 7.5),
and made to a ¢nal concentration of 1 mg/ml. One
M sodium carbonate (pH 9.2) was added to a ¢nal
concentration of 50 mM Na2CO3. 36.5 Wg Cy3, dis-
solved in 125 Wl distilled water, was added to 372 Wg
spectrin and incubated at 4‡C for 40 min. Unconju-
gated dye was removed by PD10 size exclusion chro-
matography. The Cy3 concentration was calculated
from the absorbance at 552 nm, using an extinction
coe⁄cient of 150 000 M31 cm31. The Bradford assay
was used to calculate the protein concentration. The
dye to protein ratio was typically 10:1.
2.4. Manufacture of DMPC MLVs
5 mg DMPC (50 mg/ml in chloroform/methanol
3:1) was dried thinly onto the side of a round
bottomed £ask under argon. Two ml of bu¡er at
37‡C was added to the round-bottomed £ask and
the lipids allowed to rehydrate at 37‡C for 30 min
with intermittent swirling. The vesicles were har-
vested and kept under argon at 4‡C for up to
2 days.
2.5. Binding of Cy3-spectrin to MLVs
Cy3-labelled spectrin was dialysed into 100 mM
NaCl, 10 mM sodium phosphate, 1 mM sodium
azide, 1 mM EDTA, 0.2 mM DTT (pH 7.2) and
concentrated to V1 mg/ml. Ten Wl of MLVs were
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pelleted at 5000 rpm and the pellet resuspended
in a minimum amount of bu¡er followed by addi-
tion of 100 Wl Cy3-spectrin, and incubated for
30 min at 30‡C in the dark. Unbound spectrin was
removed by pelleting the vesicles and resuspending
the pellet in bu¡er; this process was repeated three
times.
It is conceivable that some Cy3-spectrin could be-
come entrapped within the vesicles if they open and
reseal during the above procedure. To check for this
possibility, 50 Wl of MLVs were pelleted at 5000 rpm
and the pellet resuspended in 200 Wl calcein (50 WM),
and incubated for 30 min at 30‡C in the dark. The
free calcein was then removed by pelleting the
vesicles and resuspending the pellet in bu¡er; this
process was repeated three times. The vesicles were
then resuspended in 3 ml bu¡er and £uorescence
measured on a Shimadzu RF5000 at 30‡C with ex-
citation wavelength set at 495 nm and emission
scanned from 500 to 550 nm.
2.6. FRAP measurements
The FRAP system was essentially the same as de-
scribed in a previous paper [27] but with the mechan-
ical beam-splitter replaced by an electro-optic mod-
ulator [28] and the second £uorescence illumination
light source, the air-cooled argon ion laser, replaced
by a mercury lamp (Nikon, Model HB10101AF).
The optical ¢lter and dichroic mirrors described in
the previous publications [27,28] were changed to
ensure compatibility with the spectral properties of
Cy3-spectrin. A small sample of vesicles, with Cy3-
spectrin bound, were deposited on a poly-L-lysine-
coated glass microscope slide and covered with a
glass coverslip which was sealed with silicon grease.
The slide was then placed onto the temperature-con-
trolled microscope stage (Physitemp, Model TS-4)
and allowed to equilibrate to the desired temperature
prior to FRAP measurements. After equilibration,
the 514 nm beam of an argon ion laser (Innova
100-10) was focused onto the desired area on the
liposome or background. The laser beam was of
Gaussian cross-sectional intensity, with a half-width
at 1/e2 height of the laser beam at its point of focus
equal to 1.24 Wm (spot radius). FRAP measurements
were recorded and analysed as previously described
[28].
3. Results and discussion
The di¡usion of Cy3-spectrin bound to the outer
surface of DMPC MLVs was studied at three di¡er-
ent temperatures. The di¡usion coe⁄cient of Cy3-
spectrin at 30‡C, well above the gel to liquid crystal-
line phase transition of the lipid (Tc = 23.7‡C) was
found to be (2.1 þ 0.6)U1037 cm2/s with 89% of the
Fig. 1. FRAP curve of Cy3-labelled spectrin bound to the outer
lipid surface of DMPC MLVs and measured at 30‡C. The dif-
fusion coe⁄cient of Cy3-spectrin, ¢t from 30 individual
summed curves, was calculated as (2.1 þ 0.6)U1037 cm2/s with
89% of the total £uorescence recovered.
Fig. 2. FRAP curve of Cy3-labelled spectrin bound to the outer
lipid surface of DMPC MLVs and measured at 22‡C. The dif-
fusion coe⁄cient of Cy3-spectrin, ¢t from 30 individual
summed curves, was calculated as (1.28 þ 0.3)U1037 cm2/s with
90% of the total £uorescence recovered.
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£uorescence recovered after photobleaching (Fig. 1).
At 22‡C, the di¡usion coe⁄cient of Cy3-spectrin was
found to be (1.28 þ 0.25)U1037 cm2/s with 90% of
the £uorescence recovered after photobleaching
(Fig. 2). Below the phase transition, at 14‡C, the
di¡usion coe⁄cient of Cy3-spectrin was found to
be (3.1 þ 0.12)U1039 cm2/s with 71% of the £uores-
cence recovered after photobleaching (Fig. 3).
The di¡usion of Cy3-spectrin at both 22‡C and
30‡C is surprisingly fast. The di¡usion coe⁄cient is
similar to that of free Cy3-spectrin in solution, which
was shown to be (1.9 þ 0.6)U1037 cm2/s at 30‡C,
(3.4 þ 1.0)U1037 cm2/s at 22‡C and (3.1 þ 0.8)U
1037 cm2/s at 14‡C (Fig. 4), all with 100% £uores-
cence recovery. The fast di¡usion of Cy3-spectrin
bound to DMPC at 22‡C and 30‡C could be a result
of several di¡erent factors. One possibility is that the
Cy3-spectrin di¡usion coe⁄cient measured was that
of residual free Cy3-spectrin in solution. It was
clearly shown, however, that little free Cy3-spectrin
was present in solution, as FRAP measurements of
the background (i.e., away from any liposomes)
showed much weaker £uorescence intensities and
there was no recovery after photobleaching (Fig. 5).
Another possibility is that Cy3-spectrin had become
entrapped in the vesicles during the labelling and
washing procedure. For this to happen the vesicles
must break and reseal as it would be highly unlikely
for Cy3-spectrin to permeate the lipid bilayer. If
Cy3-spectrin did become entrapped within the
vesicles during the labelling and washing procedure,
it would also be expected that the Cy3-spectrin
would be removed from inside the vesicles upon sub-
sequent washing, resulting in little or no labelling. In
addition, unlabelled DMPC MLVs incubated with
calcein showed no detectable £uorescence after wash-
ing under identical conditions to those used to pre-
pare vesicles for FRAP experiments. It was assumed
that if the liposomes were breaking and resealing, the
calcein molecules would easily become entrapped
Fig. 3. FRAP curve of Cy3-labelled spectrin bound to the outer
lipid surface of DMPC MLVs and measured at 14‡C. The dif-
fusion coe⁄cient of Cy3-spectrin, ¢t from 30 individual
summed curves, was calculated as (3.1 þ 0.1)U1039 cm2/s with
71% of the total £uorescence recovered.
Fig. 4. FRAP curve of free Cy3-labelled spectrin in 100 mM
NaCl, 10 mM sodium phosphate bu¡er (pH 7.4) at 14‡C. The
di¡usion coe⁄cient of free Cy3-spectrin, ¢t from 10 individual
summed curves, was calculated as (3.1 þ 0.8)U1037 cm2/s with
100% of the total £uorescence recovered.
Fig. 5. FRAP curve of Cy3-spectrin deposited on the surface of
a poly-L-lysine-coated slide at 30‡C.
BBAMEM 77602 28-5-99
P.J. O’Toole et al. / Biochimica et Biophysica Acta 1419 (1999) 64^70 67
within the vesicles. As no evidence of calcein entrap-
ment was found, it is highly unlikely that Cy3-spec-
trin could be entrapped. The decrease in Cy3-spectrin
di¡usion at 14‡C when bound to DMPC is yet fur-
ther evidence that the high di¡usion coe⁄cients are
not due to free spectrin, since di¡usion in solution
exhibits little dependence on temperature.
It is highly unlikely that the £uorescence recovery
is a¡ected by polarised photobleaching followed by
rotational di¡usion [29,30]. Previous studies [31] have
shown that spectrin £exibility results in almost com-
plete randomisation of the probe within 10 Ws, which
is much faster than the recovery seen in these experi-
ments.
The fast di¡usion of Cy3-spectrin bound to
DMPC can be explained by multiple weak spec-
trin^lipid interactions that are constantly being brok-
en. Weak spectrin^lipid interactions do not neces-
sarily imply that spectrin molecules readily
dissociate from the lipid surface. Since spectrin has
multiple sites of lipid interaction, the spectrin mole-
cules may be able to di¡use rapidly over the surface
as individual bonds are broken and reformed whilst
the molecules remain bound to the lipid surface. For
a spectrin molecule to dissociate, it would require the
simultaneous dissociation of all its sites of lipid in-
teraction. Thus this proposed mechanism is not in
disagreement with previous studies which measure
low dissociation constants for spectrin binding
[16,17,19^21,23,32,33].
The observation of multiple weak interactions be-
tween spectrin and lipids is in agreement with Mak-
symiw et al. [19], who showed that the binding en-
ergy per mole of dimyristoylphosphatidylserine was
less than thermal energy at room temperature, and
Bitbol et al. [21], who postulated that spectrin inter-
acted with phosphatidylserine (PS) molecules by a
dipolar interaction of spectrin with the lipid^water
interface. Such interactions would enable the strong
association of spectrin with the lipid surface and also
permit fast di¡usion. A perturbation, however, of the
spectrin^lipid interactions by the covalently bound
£uorophores can not be entirely discounted.
The marked decrease in Cy3-spectrin di¡usion be-
low Tc could be a result of several di¡erent factors.
Spectrin is known to expand upon decreasing tem-
perature [34] which could result in di¡erent spectrin^
lipid interactions that are stronger than those at 22‡C
or 30‡C. MacDonald [32] showed that the apparent
Kd of spectrin for binding to PS increases upon in-
creasing temperature between 25‡C and 37‡C; how-
ever, it was also noted that the apparent maximum
spectrin binding decreased with increasing tempera-
ture which suggested di¡erent types of lipid^spectrin
interactions at di¡erent temperatures. It could there-
fore follow that at 14‡C, spectrin forms more sites of
lipid association that results in a slowing of spectrin
di¡usion on the lipid surface. The ordered lipid
structure at 14‡C could also favour stronger spec-
trin^lipid interactions as the lipids may be unable
to break free of the spectrin interactions which are
thought to occur at higher temperatures. Another
possible reason for slower di¡usion is insertion of
hydrophobic domains of spectrin into the lipid bi-
layer of the vesicles, as suggested by Mombers et
al. [16]. Spectrin has since been shown to have such
hydrophobic domains in numerous studies [35^37].
Insertion into the lipid bilayer, however, seems un-
likely as Maksymiw et al. [19] showed that spectrin
does not signi¢cantly change the phase transition
properties of DMPC bilayer vesicles, and other stud-
ies have revealed no evidence of spectrin insertion
into lipid bilayers [21].
Any residual Cy3-spectrin which is not bound to
the liposomes will bind to the polylysine coated slide
where it is immobile (see Fig. 5). When the FRAP
measurements are recorded from the vesicles it is
likely that there will be a small contribution to the
overall measurement by the out-of-focus plane £uo-
rescence of polylysine-bound Cy3-spectrin. The im-
mobile fractions seen on the vesicles can therefore be
accounted for by the background £uorescence cre-
ated by immobilised Cy3-spectrin lying underneath
the vesicles which were also deposited onto the poly-
lysine slide.
In conclusion, the present studies indicate that
spectrin^lipid coupling is via multiple weak interac-
tions that are rapidly broken and reformed. The fast
di¡usion rate suggests that spectrin^lipid interactions
contribute little to the strength of the cell membrane.
It should be noted that ankyrin binding to spectrin
results in an increase in spectrin^lipid dissociation
[22]. Once spectrin is complexed with the other mem-
bers of the erythrocyte cytoskeleton, the total surface
area of spectrin free to form spectrin^lipid interac-
tions will be much decreased. In addition, spectrin
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will be separated from the membrane by the linker
proteins, ankyrin and protein 4.1. Therefore, the
most likely role of such spectrin^lipid interactions
is to localise and concentrate unbound spectrin mol-
ecules at the lipid surface in order to facilitate pro-
tein^protein associations involved in the formation
of the erythrocyte cytoskeleton.
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